These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15763338)

  • 1. Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma.
    Tada M; Yokosuka O; Fukai K; Chiba T; Imazeki F; Tokuhisa T; Saisho H
    J Hepatol; 2005 Apr; 42(4):511-9. PubMed ID: 15763338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.
    Tchou JC; Lin X; Freije D; Isaacs WB; Brooks JD; Rashid A; De Marzo AM; Kanai Y; Hirohashi S; Nelson WG
    Int J Oncol; 2000 Apr; 16(4):663-76. PubMed ID: 10717233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
    Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells.
    Bakker J; Lin X; Nelson WG
    J Biol Chem; 2002 Jun; 277(25):22573-80. PubMed ID: 11960994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
    Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation of a non-CpG island promoter represses NQO1 expression in rat arsenic-transformed lung epithelial cells.
    Huang N; Pei X; Lin W; Chiu JF; Tao T; Li G
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):733-739. PubMed ID: 29889218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.
    Sun JZ; Yang XX; Li XH; Xu WW; Wang Y; Zhu W; Li M
    Dig Dis Sci; 2011 Oct; 56(10):3072-7. PubMed ID: 21448695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of NAD(P)H:quinone oxidoreductase 1 by hepatitis B virus X protein increases mitochondrial injury and cellular susceptibility to oxidative stress in hepatoma cells.
    Wu YL; Wang D; Peng XE; Chen YL; Zheng DL; Chen WN; Lin X
    Free Radic Biol Med; 2013 Dec; 65():632-644. PubMed ID: 23920313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K
    Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma.
    Zhang YJ; Chen Y; Ahsan H; Lunn RM; Chen SY; Lee PH; Chen CJ; Santella RM
    Cancer Lett; 2005 Apr; 221(2):135-43. PubMed ID: 15808399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
    Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
    Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma.
    Jain S; Chen S; Chang KC; Lin YJ; Hu CT; Boldbaatar B; Hamilton JP; Lin SY; Chang TT; Chen SH; Song W; Meltzer SJ; Block TM; Su YH
    PLoS One; 2012; 7(4):e35789. PubMed ID: 22536438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of aberrant promoter CpG islands hypermethylation of GSTP1 in human primary hepatocellular carcinomas].
    Wang JH; Qin Y; Li B; Sun ZL; Sun ZF; Guan QL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):686-8. PubMed ID: 16235538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.
    Yang XX; Sun JZ; Li FX; Wu YS; Du HY; Zhu W; Li XH; Li M
    World J Gastroenterol; 2012 Jun; 18(21):2719-26. PubMed ID: 22690083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.
    Wang J; Qin Y; Li B; Sun Z; Yang B
    Clin Biochem; 2006 Apr; 39(4):344-8. PubMed ID: 16527261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a non-coding KLF4 transcript generated from intron retention and downregulated in human hepatocellular carcinoma.
    Zhou J; Lai PB; Tsui SK
    Int J Oncol; 2015 Oct; 47(4):1554-62. PubMed ID: 26238073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
    Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
    World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.